Pfizer ended up passing on my GLP-1 work back in the early '90s (2024)
From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency
There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests
GLP-1 drugs linked to lower death rates in colon cancer patients
GLP-1 therapeutics: Their emerging role in alcohol and substance use disorders
Scientists from Tufts create weight-loss drug dubbed 'next Ozempic' that's twice as effective and has fewer side effects (affects not only GLP-1 and GIP, but also glucagon and peptide YY)
An injected gel could make drugs like Ozempic last longer | Less frequent dosing of GLP-1 drugs would be easier for patients
Boulevard raises $80M to power self-care boom driven by Botox and GLP-1 surge
The end of compounded GLP-1 drugs leaves many patients in a ‘lose-lose’ position
As many as 1 in 5 people won’t lose weight with GLP-1 drugs, experts say
GLP-1 for Everything
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
Drug Development Failure: how GLP-1 development was abandoned in 1990